Annual CFF
$6.78 M
-$14.65 M-68.38%
December 31, 2022
Summary
- As of February 10, 2025, BVXV annual cash flow from financing activities is $6.78 million, with the most recent change of -$14.65 million (-68.38%) on December 31, 2022.
- During the last 3 years, BVXV annual CFF has fallen by -$17.83 million (-72.46%).
Performance
BVXV Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly CFF
$0.00
$0.000.00%
June 30, 2023
Summary
- As of February 10, 2025, BVXV quarterly cash flow from financing activities is $0.00, unchanged on June 30, 2023.
- Over the past year, BVXV quarterly CFF has stayed the same.
Performance
BVXV Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM CFF
$0.00
$0.000.00%
June 30, 2023
Summary
- As of February 10, 2025, BVXV TTM cash flow from financing activities is $0.00, unchanged on June 30, 2023.
- Over the past year, BVXV TTM CFF has stayed the same.
Performance
BVXV TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
BVXV Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -68.4% | 0.0% | 0.0% |
| 3 y3 years | -72.5% | - | - |
| 5 y5 years | -61.9% | -100.0% | - |
BVXV Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -68.4% | at low | at high | at low | at high | at low |
| 5 y | 5-year | -72.5% | -37.0% | at high | at low | at high | at low |
| alltime | all time | -72.5% | -103.0% | -100.0% | <-9999.0% | -100.0% | <-9999.0% |
BiondVax Pharmaceuticals Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2023 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2023 | - | $0.00(0.0%) | $0.00(0.0%) |
| Dec 2022 | $6.78 M(-68.4%) | - | - |
| Jun 2022 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2022 | - | $0.00(-100.0%) | $0.00(-100.0%) |
| Dec 2021 | $21.43 M(+402.4%) | - | - |
| Dec 2020 | $4.27 M(-82.7%) | - | - |
| Dec 2019 | $24.61 M(+9.9%) | - | - |
| Jun 2019 | - | -$36.80 K(-57.5%) | $15.36 M(-31.1%) |
| Mar 2019 | - | -$86.50 K(-101.0%) | $22.30 M(-0.4%) |
| Dec 2018 | $22.39 M(+25.8%) | $8.36 M(+17.3%) | $22.39 M(+57.1%) |
| Sep 2018 | - | $7.12 M(+3.1%) | $14.25 M(-28.4%) |
| Jun 2018 | - | $6.91 M(>+9900.0%) | $19.91 M(+34.7%) |
| Mar 2018 | - | $0.00(-100.0%) | $14.78 M(-16.9%) |
| Dec 2017 | $17.79 M | $220.00 K(-98.3%) | $17.79 M(+1.3%) |
| Sep 2017 | - | $12.78 M(+618.8%) | $17.57 M(+267.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2017 | - | $1.78 M(-40.9%) | $4.79 M(+59.1%) |
| Mar 2017 | - | $3.01 M(>+9900.0%) | $3.01 M(>+9900.0%) |
| Dec 2016 | $0.00(-100.0%) | $0.00(0.0%) | $0.00(-100.0%) |
| Sep 2016 | - | $0.00(0.0%) | $56.00 K(-119.7%) |
| Jun 2016 | - | $0.00(0.0%) | -$283.60 K(-103.3%) |
| Mar 2016 | - | $0.00(-100.0%) | $8.69 M(+0.5%) |
| Dec 2015 | $8.65 M(-4406.0%) | $56.00 K(-116.5%) | $8.65 M(+3.1%) |
| Sep 2015 | - | -$339.60 K(-103.8%) | $8.39 M(-3.9%) |
| Jun 2015 | - | $8.97 M(<-9900.0%) | $8.73 M(-3670.2%) |
| Mar 2015 | - | -$43.70 K(-78.2%) | -$244.50 K(+21.8%) |
| Dec 2014 | -$200.80 K(-107.6%) | -$200.80 K(<-9900.0%) | -$200.80 K(<-9900.0%) |
| Sep 2014 | - | $0.00(0.0%) | $0.00(0.0%) |
| Jun 2014 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2014 | - | $0.00 | $0.00 |
| Dec 2013 | $2.66 M(+101.0%) | - | - |
| Dec 2012 | $1.32 M(+6.2%) | - | - |
| Dec 2011 | $1.24 M | - | - |
FAQ
- What is BiondVax Pharmaceuticals annual cash flow from financing activities?
- What is the all time high annual CFF for BiondVax Pharmaceuticals?
- What is BiondVax Pharmaceuticals annual CFF year-on-year change?
- What is BiondVax Pharmaceuticals quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for BiondVax Pharmaceuticals?
- What is BiondVax Pharmaceuticals quarterly CFF year-on-year change?
- What is BiondVax Pharmaceuticals TTM cash flow from financing activities?
- What is the all time high TTM CFF for BiondVax Pharmaceuticals?
- What is BiondVax Pharmaceuticals TTM CFF year-on-year change?
What is BiondVax Pharmaceuticals annual cash flow from financing activities?
The current annual CFF of BVXV is $6.78 M
What is the all time high annual CFF for BiondVax Pharmaceuticals?
BiondVax Pharmaceuticals all-time high annual cash flow from financing activities is $24.61 M
What is BiondVax Pharmaceuticals annual CFF year-on-year change?
Over the past year, BVXV annual cash flow from financing activities has changed by -$14.65 M (-68.38%)
What is BiondVax Pharmaceuticals quarterly cash flow from financing activities?
The current quarterly CFF of BVXV is $0.00
What is the all time high quarterly CFF for BiondVax Pharmaceuticals?
BiondVax Pharmaceuticals all-time high quarterly cash flow from financing activities is $12.78 M
What is BiondVax Pharmaceuticals quarterly CFF year-on-year change?
Over the past year, BVXV quarterly cash flow from financing activities has changed by $0.00 (0.00%)
What is BiondVax Pharmaceuticals TTM cash flow from financing activities?
The current TTM CFF of BVXV is $0.00
What is the all time high TTM CFF for BiondVax Pharmaceuticals?
BiondVax Pharmaceuticals all-time high TTM cash flow from financing activities is $22.39 M
What is BiondVax Pharmaceuticals TTM CFF year-on-year change?
Over the past year, BVXV TTM cash flow from financing activities has changed by $0.00 (0.00%)